Clinical Chemistry Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 50: 433-435, 2004; 10.1373/clinchem.2003.027326
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kazmierczak, S. C.
Right arrow Articles by Gourley, G. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kazmierczak, S. C.
Right arrow Articles by Gourley, G. R.
Related Collections
Right arrow Pediatric Clinical Chemistry
Right arrow Point-of-Care Testing
(Clinical Chemistry. 2004;50:433-435.)
© 2004 American Association for Clinical Chemistry, Inc.


Technical Briefs

Transcutaneous Measurement of Bilirubin in Newborns: Comparison with an Automated Jendrassik–Grof Procedure and HPLC

Steven C. Kazmierczak1,a, Alex F. Robertson2, Kimberly P. Briley3, Bill Kreamer4 and Glenn R. Gourley4,5

Departments of1 Pathology and 5 Pediatrics, Oregon Health and Science University, Portland, OR; Departments of2 Pediatrics and Pathology and 3 Laboratory Medicine, The Brody School of Medicine at East Carolina University, Greenville, NC;4 Waisman Center, University of Wisconsin, Madison, WI

aaddress correspondence to this author at: Department of Pathology, Oregon Health and Science University, 3181 SW Sam Jackson Park Rd., Mailcode L-471, Portland, OR 97239; e-mail kazmierc@ohsu.edu

The first 300 words of the full text of this article appear below.

Measurement of bilirubin in sera of newborn infants is one of the most frequently performed laboratory tests in this patient population (1)(2)(3)(4). Chemical methods for measurement of bilirubin are the standard of care in the assessment of neonatal jaundice. However, transcutaneous techniques for assessing in vivo bilirubin concentrations have been advocated as a more cost-effective and less traumatic alternative to the collection of blood by heel puncture (2)(3).

Studies have varied in their assessment of the accuracy of transcutaneous bilirubin assessment; poor to excellent agreement between transcutaneous bilirubin measurements and bilirubin measured in plasma has been reported (1)(2)(3)(5)(6)(7)(8)(9). The best agreement between transcutaneous bilirubin measurements and measurement of plasma bilirubin concentrations has been reported for studies using homogeneous populations of newborns with comparable basal skin color (9). Unfortunately, many factors, such as hemoglobin concentration, the pH and bilirubin-binding capacity of albumin, the technique used to obtain the blood sample, skin pigmentation, and requirement by some methods for baseline measurement of skin color immediately after birth, can significantly effect the agreement between transcutaneous and chemical methods for bilirubin (6)(10)(11).

We evaluated the BiliCheck point-of-care device (Respironics, Marietta, GA), which performs transcutaneous measurement of bilirubin by multiwavelength spectral analysis. We compared results obtained with the BiliCheck with bilirubin concentrations in blood specimens measured in a hospital laboratory. In addition, we also measured bilirubin by HPLC. Although HPLC is labor-intensive and not practical for routine use, this method is not subject to interference from hemoglobin or lipemia. Our goals were to evaluate the accuracy of the BiliCheck method compared with a laboratory-based bilirubin method, using HPLC as . . . [Full Text of this Article]




The following articles in journals at HighWire Press have cited this article:


Home page
Clin. Chem.Home page
J. R. Petersen, A. O. Okorodudu, A. A. Mohammad, A. Fernando, and K. E. Shattuck
Association of Transcutaneous Bilirubin Testing in Hospital with Decreased Readmission Rate for Hyperbilirubinemia
Clin. Chem., March 1, 2005; 51(3): 540 - 544.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Association for Clinical Chemistry.